Business Description
Orion Infusions Ltd
ISIN : BD0472ORINF6
Total Employee Number:
563Description
Orion Infusions Ltd is a pharmaceutical company engaged in the production of various types of intravenous fluids, rehydration solutions, electrolyte solutions, and solutions for acidosis, as well as Ranitidine I.V. infusion and anti-microbial products such as Ciprofloxacin I.V. and Metronidazole I.V. The Company's products include Dextrolac, Dextropac, Dextrosal, Dianak, Electro Dex, Fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the Group operates across several sectors, including pharma and healthcare, power and energy, infrastructure development, real estate, cosmetics and toiletries, consumer products, textiles and garments, and home appliances. Geographically, the Company operates in Bangladesh.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.9 | |||||
Debt-to-EBITDA | 3.04 | |||||
Interest Coverage | 2.08 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 8.41 | |||||
Beneish M-Score | -2.27 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.1 | |||||
3-Year EBITDA Growth Rate | -3.1 | |||||
3-Year EPS without NRI Growth Rate | -6.2 | |||||
3-Year FCF Growth Rate | -7.4 | |||||
3-Year Book Growth Rate | 4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.68 | |||||
9-Day RSI | 33.39 | |||||
14-Day RSI | 35.22 | |||||
3-1 Month Momentum % | -4.24 | |||||
6-1 Month Momentum % | -10.34 | |||||
12-1 Month Momentum % | -8.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.97 | |||||
Quick Ratio | 0.72 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 124.7 | |||||
Days Sales Outstanding | 82.32 | |||||
Days Payable | 49.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.69 | |||||
Dividend Payout Ratio | 1.16 | |||||
3-Year Dividend Growth Rate | 6.3 | |||||
Forward Dividend Yield % | 0.69 | |||||
5-Year Yield-on-Cost % | 0.68 | |||||
Shareholder Yield % | 0.82 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.36 | |||||
Operating Margin % | 11.47 | |||||
Net Margin % | 5.48 | |||||
EBITDA Margin % | 15.01 | |||||
FCF Margin % | 10.19 | |||||
OCF Margin % | 10.3 | |||||
ROE % | 10.84 | |||||
ROA % | 4.2 | |||||
ROIC % | 7.67 | |||||
3-Year ROIIC % | 11.37 | |||||
ROC (Joel Greenblatt) % | 13.03 | |||||
ROCE % | 22.47 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 167.35 | |||||
PE Ratio without NRI | 169.3 | |||||
Shiller PE Ratio | 118.45 | |||||
Price-to-Owner-Earnings | 125.78 | |||||
PEG Ratio | 564.33 | |||||
PS Ratio | 9.16 | |||||
PB Ratio | 17.97 | |||||
Price-to-Tangible-Book | 17.96 | |||||
Price-to-Free-Cash-Flow | 89.93 | |||||
Price-to-Operating-Cash-Flow | 88.94 | |||||
EV-to-EBIT | 77.44 | |||||
EV-to-EBITDA | 63.92 | |||||
EV-to-Revenue | 9.59 | |||||
EV-to-FCF | 96.11 | |||||
Price-to-GF-Value | 0.92 | |||||
Price-to-Projected-FCF | 11.4 | |||||
Price-to-Median-PS-Value | 4.07 | |||||
Price-to-Graham-Number | 11.62 | |||||
Earnings Yield (Greenblatt) % | 1.29 | |||||
FCF Yield % | 1.12 | |||||
Forward Rate of Return (Yacktman) % | -1.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orion Infusions Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | 647.553 | ||
| EPS (TTM) (BDT) | 1.74 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.18 | ||
| 3-Year Sortino Ratio | 0.33 | ||
| Volatility % | 63.35 | ||
| 14-Day RSI | 35.22 | ||
| 14-Day ATR (BDT) | 7.238208 | ||
| 20-Day SMA (BDT) | 303.585 | ||
| 12-1 Month Momentum % | -8.64 | ||
| 52-Week Range (BDT) | 285 - 587.5 | ||
| Shares Outstanding (Mil) | 20.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orion Infusions Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orion Infusions Ltd Stock Events
| Event | Date | Price (BDT) | ||
|---|---|---|---|---|
| BDT 2.000000 Cash Dividend | 2025-12-02 | 389.00 (+0.00%) | ||
| BDT 1.200000 Cash Dividend | 2024-12-05 | 302.90 (+0.00%) | ||
| 1.1:1 Stock Split | 2022-12-05 | 527.50 (+0.00%) |
Show
Entries
Orion Infusions Ltd Frequently Asked Questions
What is Orion Infusions Ltd(DHA:ORIONINFU)'s stock price today?
The current price of DHA:ORIONINFU is BDT291.20. The 52 week high of DHA:ORIONINFU is BDT587.50 and 52 week low is BDT285.00.
When is next earnings date of Orion Infusions Ltd(DHA:ORIONINFU)?
The next earnings date of Orion Infusions Ltd(DHA:ORIONINFU) is .
Does Orion Infusions Ltd(DHA:ORIONINFU) pay dividends? If so, how much?
The Dividend Yield %  of Orion Infusions Ltd(DHA:ORIONINFU) is 0.69% (As of Today), Highest Dividend Payout Ratio of Orion Infusions Ltd(DHA:ORIONINFU) was 1.16. The lowest was 0.25. And the median was 0.71. The  Forward Dividend Yield % of Orion Infusions Ltd(DHA:ORIONINFU) is 0.69%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Orion Infusions Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers